Organisation paid for research Program year 2023 Source: CMS Open Payments

Premier Research Associate Inc

Neither a doctor nor a teaching hospital

Research payments

$1,109,764

49 payments

Through program year 2023, Premier Research Associate Inc is reported as receiving $1,109,764 in research payments, across 49 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$473	1
2022	Research	$640,588	13
2021	Research	$828	2
2020	Research	$70,131	15
2019	Research	$397,745	18

Breakdown

Who paid Research payments · program years 2019–2023

Janssen Research & Development, LLC $633,827 11 payments
GlaxoSmithKline, LLC. $250,364 5 payments
Genentech, Inc. $179,372 18 payments
Vanda Pharmaceuticals Inc. $38,562 11 payments
Lexicon Pharmaceuticals, Inc. $5,474 1 payment
AbbVie, Inc. $2,009 1 payment
Akebia Therapeutics Inc $155 2 payments

Studies the money was for Research payments · program years 2019–2023

A Randomized, Double-blind, Phase 3 Study to Evaluate Safety, Reactogenicity, and Immunogenicity of Co-administration of Ad26.COV2.S and Influenza Vaccines in Healthy Adults 18 Years of Age and Older $633,827 11 payments
A Phase IV, 12-Week, Randomised, Double-Blind, Triple Dummy Study to C $250,364 5 payments
A Phase Ib Randomized Blinded Placebo Controlled Multiple Ascending Dose Study With Bfkb8488a $168,138 14 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis $38,562 11 payments
Phase II Antifgfr 1 in Nash $7,234 3 payments
Efc-14875 $5,474 1 payment
Transmission Study Household $4,000 1 payment
M11-352 $2,009 1 payment
Akb-6548-Ci-0014 $78 1 payment
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (Ndd-Ckd) (Pro2tect-Correction) $78 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.